The effect of a novel polysaccharide blend (PGX® micro-granules) on short- term weight loss and other laboratory parameters in overweight and obese adults: an observational retrospective analysis
Not Applicable
- Conditions
- Overweight/obesityNutritional, Metabolic, EndocrineObesity
- Registration Number
- ISRCTN50749194
- Lead Sponsor
- Factors Group of Nutritional Companies Inc. (Canada)
- Brief Summary
Results article in https://pubmed.ncbi.nlm.nih.gov/20359270/ (added 19/07/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Not specified
- Target Recruitment
- 29
Inclusion Criteria
1. 20 to 65 year of age
2. Body mass index range of approximately 23 kg/m^2 to 35 kg/m^2
3. Otherwise healthy
Exclusion Criteria
1. Morbid obesity
2. Major psychiatric diagnosis
3. Use of other weight loss medications such as sibutramine or ephedra
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes measured for all participants are weight (pounds), waist and hip circumference, and percent body fat. Percent body fat was determined using bioelectrical impedance testing at baseline and every two weeks thereafter.
- Secondary Outcome Measures
Name Time Method All subjects enrolled in the program were initially evaluated for High Density Lipoprotein (HDL), LDL, total cholesterol, triglycerides, fasting glucose, fasting insulin, two hour fasting insulin, and 75 gram glucose tolerance test at baseline, only those with aberrant risk factors were re-tested using the latter laboratory parameters at week 14.